Flupamesone

Flupamesone (brand name Flutenal), also known as triamcinolone acetonide metembonate, is a synthetic glucocorticoid corticosteroid which is marketed in Spain.[2][3][4][1] It is a dimer of a C21 ester of triamcinolone acetonide.[2][3][1]

Flupamesone
Clinical data
Trade namesFlutenal
Other namesUR-105; Triamcinolone acetonide metembonate; 4,4'-Methylene-bis((9α-fluoro-11β,21-dihydroxy-16α,17α-isopropylidenedioxypregna-1,4-diene-3,20-dione)3-methoxy-2-naphthoate); 21,21'-[Methylenebis[(2-methoxy-1,3-naphthalenediyl)-
carbonyloxy]]bis[9α-fluoro-11β-hydroxy-16α,17α-[(1-methylethylidene)-
bis(oxy)]pregna-1,4-diene-3,20-dione
Routes of
administration
Topical[1]
Drug classCorticosteroid; Glucocorticoid
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ECHA InfoCard100.054.209
Chemical and physical data
FormulaC73H78F2O16
Molar mass1249.408 g·mol−1
3D model (JSmol)

References

  1. Rimbau V, Lleonart F (1975). "Kinetic study of the percutaneous absorption of 1,2,4-3H-labelled flupamesone". Arzneimittelforschung. 25 (7): 1040–2. PMID 1174410.
  2. J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 568–. ISBN 978-1-4757-2085-3.
  3. Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 461–. ISBN 978-3-88763-075-1.
  4. https://www.drugs.com/international/flupamesone.html



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.